TAK-700 (Orteronel)

CAS No. 566939-85-3

TAK-700 (Orteronel) ( Orteronel )

Catalog No. M15061 CAS No. 566939-85-3

Orteronel(TAK-700) was selected as a candidate for clinical evaluation.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 688 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TAK-700 (Orteronel)
  • Note
    Research use only, not for human use.
  • Brief Description
    Orteronel(TAK-700) was selected as a candidate for clinical evaluation.
  • Description
    Orteronel(TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.
  • Synonyms
    Orteronel
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    20-lyase(Rat); 20-lyase(Human)
  • Research Area
    Cancer
  • Indication
    Prostate Cancer

Chemical Information

  • CAS Number
    566939-85-3
  • Formula Weight
    307.35
  • Molecular Formula
    CHNO
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO:61 mg/mL (198.47 mM); Ethanol:8 mg/mL (26.02 mM);Water:<1 mg/mL
  • SMILES
    CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)[C@]3(CCN4C3=CN=C4)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamaoka M, et al. J Steroid Biochem Mol Biol. 2012, 129(3-5), 115-128.
molnova catalog
related products
  • Tiliroside

    Tiliroside shows antioxidant and anti-inflammatory activity, can inhibit neuroinflammation in neurodegenerative disorders.

  • Bazedoxifene HCl

    Bazedoxifene HCl is a novel, non-steroidal, indole-based estrogen receptor modulator (SERM) binding to both ERα and ERβ with IC50 of 23 nM and 89 nM, respectively.

  • DMU2139

    DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).